216 related articles for article (PubMed ID: 32071730)
21. Inappropriate dosing of direct oral anticoagulants: findings from a clinical vignette study and physician survey.
Fuat A; Ako E; Hargroves D; Holden D; Caleyachetty A; Carter M; Harris J; Roberts C; Nzeakor N; Vardar B; Williams H
J Mark Access Health Policy; 2023; 11(1):2267327. PubMed ID: 37954532
[TBL] [Abstract][Full Text] [Related]
22. Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis.
Shen NN; Zhang C; Hang Y; Li Z; Kong LC; Wang N; Wang JL; Gu ZC
Front Pharmacol; 2021; 12():581293. PubMed ID: 34122056
[No Abstract] [Full Text] [Related]
23. Burden of Inappropriate Prescription of Direct Oral Anticoagulants at Hospital Admission and Discharge in the Elderly: A Prospective Observational Multicenter Study.
Bruneau A; Schwab C; Anfosso M; Fernandez C; Hindlet P
Drugs Aging; 2019 Nov; 36(11):1047-1055. PubMed ID: 31486994
[TBL] [Abstract][Full Text] [Related]
24. Inappropriate Dosing of Direct Oral Anticoagulants in Patients with Atrial Fibrillation.
Sugrue A; Sanborn D; Amin M; Farwati M; Sridhar H; Ahmed A; Mehta R; Siontis KC; Mulpuru SK; Deshmukh AJ; Gersh BJ; Asirvatham SJ; Madhavan M
Am J Cardiol; 2021 Apr; 144():52-59. PubMed ID: 33385355
[TBL] [Abstract][Full Text] [Related]
25. Appropriateness of the Direct Oral Anticoagulants Dosing in the Middle East Gulf Region.
Anouassi Z; Atallah B; Alsoud LO; El Nekidy W; Al Mahmeed W; AlJaabari M; Almuti K
J Cardiovasc Pharmacol; 2021 Feb; 77(2):182-188. PubMed ID: 32925474
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Direct Oral Anticoagulant Dosing and Monitoring in Two Geriatric Outpatient Clinics.
Howerton MA; Suhrie EM; Gennari AS; Jones N; Ruby CM
Sr Care Pharm; 2019 Mar; 34(3):192-205. PubMed ID: 31155026
[No Abstract] [Full Text] [Related]
27. Appropriateness of Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation: Insights From the Veterans Health Administration.
Leef GC; Perino AC; Askari M; Fan J; Ho PM; Olivier CB; Longo L; Mahaffey KW; Turakhia MP
J Pharm Pract; 2020 Oct; 33(5):647-653. PubMed ID: 30791808
[TBL] [Abstract][Full Text] [Related]
28. Oral Anticoagulant Use in Elderly Japanese Patients With Non-Valvular Atrial Fibrillation - Subanalysis of the ANAFIE Registry.
Akao M; Shimizu W; Atarashi H; Ikeda T; Inoue H; Okumura K; Koretsune Y; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamashita T; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A
Circ Rep; 2020 Oct; 2(10):552-559. PubMed ID: 33693180
[No Abstract] [Full Text] [Related]
29. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
[TBL] [Abstract][Full Text] [Related]
30. Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards.
De Vincentis A; Soraci L; Arena E; Sciacqua A; Armentaro G; Aucella F; Corsonello A; Aucella F; Antonelli Incalzi R
Br J Clin Pharmacol; 2024 May; 90(5):1231-1239. PubMed ID: 38321367
[TBL] [Abstract][Full Text] [Related]
31. Use of Direct Oral Anticoagulants in Canadian Primary Care Practice 2010-2015: A Cohort Study From the Canadian Primary Care Sentinel Surveillance Network.
McAlister FA; Garrison S; Kosowan L; Ezekowitz JA; Singer A
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374047
[TBL] [Abstract][Full Text] [Related]
32. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
Jackevicius CA; Lu L; Ghaznavi Z; Warner AL
Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109
[TBL] [Abstract][Full Text] [Related]
33. Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation.
Rymer JA; Webb L; McCall D; Hills MT; Wang TY
J Am Heart Assoc; 2021 Jun; 10(11):e020697. PubMed ID: 33998252
[TBL] [Abstract][Full Text] [Related]
34. [ANMCO Position paper: Prescription appropriateness of direct oral anticoagulants for stroke and systemic thromboembolis with non-valvular atrial fibrillation].
Mocini D; Di Fusco SA; De Luca L; Caldarola P; Cipriani M; Corda M; Di Lenarda A; De Nardo A; Francese GM; Napoletano C; Navazio A; Riccio C; Roncon L; Tizzani E; Urbinati S; Valente S; Gulizia MM; Gabrielli D; Oliva F; Colivicchi F
G Ital Cardiol (Rome); 2021 Dec; 22(12):1024-1033. PubMed ID: 34845405
[TBL] [Abstract][Full Text] [Related]
35. Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A Population-Based Cohort Study.
Lau WCY; Cheung CL; Man KKC; Chan EW; Sing CW; Lip GYH; Siu CW; Lam JKY; Lee ACH; Wong ICK
Ann Intern Med; 2020 Jul; 173(1):1-9. PubMed ID: 32423351
[TBL] [Abstract][Full Text] [Related]
36. A retrospective study on the evaluation of the appropriateness of oral anticoagulant therapy for patients with atrial fibrillation.
Qian Y; Zhang J; Li J; Weng Z
PLoS One; 2021; 16(11):e0259199. PubMed ID: 34762667
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a pharmacist-led outpatient direct oral anticoagulant service.
Ashjian E; Kurtz B; Renner E; Yeshe R; Barnes GD
Am J Health Syst Pharm; 2017 Apr; 74(7):483-489. PubMed ID: 28336758
[TBL] [Abstract][Full Text] [Related]
38. Medication adherence to direct anticoagulants in patients with non-valvular atrial fibrillation - A real world analysis.
Brízido C; Ferreira AM; Lopes P; Strong C; Sá Mendes G; Fernandes Gama F; Durazzo A; Rocha Rodrigues G; Matos D; Guerreiro S; Madeira S; Ferreira J; Adragão P; Mendes M
Rev Port Cardiol (Engl Ed); 2021 Sep; 40(9):669-675. PubMed ID: 34503705
[TBL] [Abstract][Full Text] [Related]
39. The treatment pattern and adherence to direct oral anticoagulants in patients with atrial fibrillation aged over 65.
Han S; Jeong HS; Kim H; Suh HS
PLoS One; 2019; 14(4):e0214666. PubMed ID: 30934004
[TBL] [Abstract][Full Text] [Related]
40. Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants.
Camm AJ; Cools F; Virdone S; Bassand JP; Fitzmaurice DA; Arthur Fox KA; Goldhaber SZ; Goto S; Haas S; Mantovani LG; Kayani G; Grierson Turpie AG; Antoon Verheugt FW; Kakkar AK;
J Am Coll Cardiol; 2020 Sep; 76(12):1425-1436. PubMed ID: 32943160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
